Home/Filings/4/0001225208-25-002655
4//SEC Filing

Woodworth Emily 4

Accession 0001225208-25-002655

CIK 0000885725other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:11 PM ET

Size

13.6 KB

Accession

0001225208-25-002655

Insider Transaction Report

Form 4
Period: 2025-02-28
Woodworth Emily
SVP, Global Controller and CAO
Transactions
  • Sale

    Common Stock

    2025-02-28$101.13/sh9,887$999,8721,632 total
  • Exercise/Conversion

    Common Stock

    2025-03-01+8372,469 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-018372,514 total
    Exp: 2028-03-01Common Stock (837 underlying)
  • Tax Payment

    Common Stock

    2025-03-01$103.79/sh355$36,8452,114 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-02-287,2180 total
    Exercise: $42.16Exp: 2030-02-18Common Stock (7,218 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-28$42.16/sh+7,218$304,31111,519 total
Footnotes (4)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
  • [F2]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F3]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
  • [F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0002013518

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:11 PM ET
Size
13.6 KB